Thus, we hypothesized that ox-LDL promoted ILF3 overexpression and promoted proliferation, cell cycle, migration, and invasion of gastric cancer cells via PI3K/AKT/mTOR signaling pathway, and that statins might be the targeted drugs to treat GC in clinical practice. The gene discussed is AKT1; the disease is gastric cancer.